Phase II Study of Efficacy of Vitamin D Supplementation in Multiple Sclerosis.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Colecalciferol (Primary) ; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms EVIDIMS
- 29 Jul 2021 Biomarkers information updated
- 12 Sep 2013 Planned end date changed from 1 Mar 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 10 Jul 2012 Planned End Date changed from 19 Sep 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.